Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06223789 · ClinicalTrials.gov registry record · NA
VOLT-AF IDE Clinical Study
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 392
- Enrollment target
NCT06223789 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 392 participants.
The verdict
NCT06223789, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 392 participants
- Enrollment target
Study Summary
This clinical investigation is intended to demonstrate safety and effectiveness of the Volt™ Pulsed Field Ablation (PFA) Catheter Sensor Enabled™, the Volt™ PFA Generator, Agilis™ NxT Steerable Introducer Dual-Reach™, and EnSite™ X EP System EnSite™ Pulsed Field Ablation Module (for simplicity of reference this device collection will hereafter be referred to as the Volt™ PFA system) for the treatment of symptomatic, recurrent, drug-refractory paroxysmal and persistent atrial fibrillation.
Interventions
- DEVICE Pulsed Field Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 392 participants |
| Start Date | 2024-04-03 |
| Est. Completion | 2025-10-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06223789
The ClinicalTrials.gov registry entry for NCT06223789 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 392 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulsed Field Ablation is the first listed.
NCT06223789 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06223789 about?
NCT06223789 is a clinical study titled "VOLT-AF IDE Clinical Study". This clinical investigation is intended to demonstrate safety and effectiveness of the Volt™ Pulsed Field Ablation (PFA) Catheter Sensor Enabled™, the Volt™ PFA Generator, Agilis™ NxT Steerable Introducer Dual-Reach™, and EnSite™ X EP System EnSite™ Pulsed Field Ablation Module (for simplicity of re...
What is the current status of trial NCT06223789?
This trial is currently completed. It is a NA study. The enrollment target is 392 participants. The study started on 2024-04-03. Estimated completion is 2025-10-03.
What interventions are being tested in trial NCT06223789?
The interventions under investigation include: Pulsed Field Ablation (DEVICE).
Who is sponsoring clinical trial NCT06223789?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.